NASDAQ
Enzon Pharmaceuticals, Inc. (ENZN) has a fcf yield of -107.01% as of Friday, May 29, 2026. This represents a 1968.06% decrease compared to its 12-month average of 5.73%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.